Elevated systemic immune inflammation level increases the risk of total and cause-specific mortality among patients with chronic kidney disease: a large multi-center longitudinal study

[1]  A. Garg,et al.  Cancer Risk and Mortality in Patients With Kidney Disease: A Population-Based Cohort Study. , 2022, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[2]  C. Kovesdy.  Epidemiology of chronic kidney disease: an update 2022. , 2022, Kidney international supplements.

[3]  Yi Luan,et al.  Systemic Immune-Inflammation Index Predicts Contrast-Induced Acute Kidney Injury in Patients Undergoing Coronary Angiography: A Cross-Sectional Study , 2022, Frontiers in Medicine.

[4]  Wei Li,et al.  The Efficacy of Different Inflammatory Markers for the Prognosis of Patients with Malignant Tumors , 2021, Journal of inflammation research.

[5]  A. Tosu,et al.  Association of systemic immune-inflammation index (SII) with presence of isolated coronary artery ectasia , 2021, Archives of medical sciences. Atherosclerotic diseases.

[6]  M. Johansson,et al.  Systemic inflammation markers and cancer incidence in the UK Biobank , 2021, European Journal of Epidemiology.

[7]  H. Anders,et al.  From Kidney Injury to Kidney Cancer. , 2021, Kidney international.

[8]  S. Dudley,et al.  Magnesium, Oxidative Stress, Inflammation, and Cardiovascular Disease , 2020, Antioxidants.

[9]  N. Soudani,et al.  Molecular Insights Into SARS COV-2 Interaction With Cardiovascular Disease: Role of RAAS and MAPK Signaling , 2020, Frontiers in Pharmacology.

[10]  Yenn-Jiang Lin,et al.  Systemic immune‐inflammation index (SII) predicted clinical outcome in patients with coronary artery disease , 2020, European journal of clinical investigation.

[11]  H. Morgenstern,et al.  US Renal Data System 2019 Annual Data Report: Epidemiology of Kidney Disease in the United States. , 2019, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[12]  R. de Caterina,et al.  Platelet Indices and Risk of Death and Cardiovascular Events: Results from a Large Population-Based Cohort Study , 2019, Thrombosis and Haemostasis.

[13]  C. Ronco,et al.  Neurohormonal, Endocrine, and Immune Dysregulation and Inflammation in Cardiorenal Syndrome , 2019, Cardiorenal Medicine.

[14]  D. Mikhailidis,et al.  Arterial Stiffness in the Heart Disease of CKD. , 2019, Journal of the American Society of Nephrology : JASN.

[15]  Wan-Hai Wang,et al.  Prognostic value of Systemic immune-inflammation index in cancer: A meta-analysis , 2018, Journal of Cancer.

[16]  G. Anton,et al.  Inflammation-Related Mechanisms in Chronic Kidney Disease Prediction, Progression, and Outcome , 2018, Journal of immunology research.

[17]  C. Zazueta,et al.  Oxidative Stress and Inflammation in Cardiovascular Disease , 2017, Oxidative medicine and cellular longevity.

[18]  A. Gorini,et al.  [Atherosclerosis, chronic inflammation and oxidative stress in CKD]. , 2017, Giornale Italiano di Nefrologia.

[19]  C. Weber,et al.  Neutrophil Extracellular Traps in Atherosclerosis and Atherothrombosis , 2017, Circulation research.

[20]  P. Bachellier,et al.  Additive value of pre-operative and one-month post-operative lymphocyte count for death-risk stratification in patients with resectable pancreatic cancer: a multicentric study , 2016, BMC Cancer.

[21]  P. Mitchell,et al.  Chronic kidney disease and the risk of cancer: an individual patient data meta-analysis of 32,057 participants from six prospective studies , 2016, BMC Cancer.

[22]  J. Śanchez-Corona,et al.  The renin-angiotensin system meets the hallmarks of cancer , 2015, Journal of the renin-angiotensin-aldosterone system : JRAAS.

[23]  Connie M. Rhee,et al.  Epidemiology: Spotlight on CKD deaths—increasing mortality worldwide , 2015, Nature Reviews Nephrology.

[24]  Bernadette A. Thomas,et al.  Global, regional, and national age–sex specific all-cause and cause-specific mortality for 240 causes of death, 1990–2013: a systematic analysis for the Global Burden of Disease Study 2013 , 2015, The Lancet.

[25]  P. Horák,et al.  Pathophysiology of anemia in chronic kidney diseases: A review. , 2014, Biomedical papers of the Medical Faculty of the University Palacky, Olomouc, Czechoslovakia.

[26]  Chi Pang Wen,et al.  Chronic kidney disease and cardiovascular risk: epidemiology, mechanisms, and prevention , 2013, The Lancet.

[27]  P. Stenvinkel,et al.  Inflammation in End‐Stage Renal Disease—What Have We Learned in 10 Years? , 2010, Seminars in dialysis.

[28]  P. Barlis,et al.  Frequency and predictors of contrast-induced nephropathy after angioplasty for chronic total occlusions. , 2010, International journal of cardiology.

[29]  M. Pencina,et al.  Evaluating the added predictive ability of a new marker: From area under the ROC curve to reclassification and beyond , 2008, Statistics in medicine.

[30]  J. Griffith,et al.  The Framingham predictive instrument in chronic kidney disease. , 2007, Journal of the American College of Cardiology.

[31]  R. O’Brien,et al.  A Caution Regarding Rules of Thumb for Variance Inflation Factors , 2007 .

[32]  N. Powe,et al.  Traditional cardiovascular disease risk factors in dialysis patients compared with the general population: the CHOICE Study. , 2002, Journal of the American Society of Nephrology : JASN.

[33]  A. Levey,et al.  A More Accurate Method To Estimate Glomerular Filtration Rate from Serum Creatinine: A New Prediction Equation , 1999, Annals of Internal Medicine.

[34]  J. Carrero,et al.  Therapeutics targeting persistent inflammation in chronic kidney disease. , 2016, Translational research : the journal of laboratory and clinical medicine.

[35]  M. Nakayama,et al.  Stroke and chronic kidney disease , 2009 .